Author:
Sun Shihui,He Lei,Zhao Zhongpeng,Gu Hongjing,Fang Xin,Wang Tiecheng,Yang Xiaolan,Chen Shaolong,Deng Yongqiang,Li Jiangfan,Zhao Jian,Li Liang,Li Xinwang,He Peng,Li Ge,Li Hao,Zhao Yuee,Gao Chunrun,Lang Xiaoling,Wang Xin,Fei Guoqiang,Li Yan,Geng Shusheng,Gao Yuwei,Wei Wenjin,Hu Zhongyu,Han Gencheng,Sun Yansong
Funder
National Natural Science Foundation of China
Publisher
Springer Science and Business Media LLC
Subject
Infectious Diseases,Immunology,Immunology and Allergy
Reference10 articles.
1. Quinlan, B. D. et al. The SARS-CoV-2 receptor-binding domain elicits a potent neutralizing response without antibody-dependent enhancement. 2020.2004.2010.036418, https://doi.org/10.1101/2020.04.10.036418%JbioRxiv (2021).
2. Yang, J. et al. A vaccine targeting the RBD of the S protein of SARS-CoV-2 induces protective immunity. Nature 586, 572–577 (2020).
3. Wieland, A. & Ahmed, R. Fc receptors in antimicrobial protection. Curr. Top. Microbiol. Immunol. 423, 119–150 (2019).
4. Martyn, J. C. et al. Surface display of IgG Fc on baculovirus vectors enhances binding to antigen-presenting cells and cell lines expressing Fc receptors. Arch. Virol. 154, 1129–1138 (2009).
5. Li, Y. et al. A recombinant protein containing highly conserved hemagglutinin residues 81-122 of influenza H5N1 induces strong humoral and mucosal immune responses. Biosci. Trends 7, 129–137 (2013).